SYNAPTIC MARKER PROTEIN SV2A IS REDUCED IN SCHIZOPHRENIA IN VIVO AND UNAFFECTED BY ANTIPSYCHOTICS IN RATS

被引:0
|
作者
Onwordi, Ellis Chika [1 ]
Halff, Els [2 ]
Whitehurst, Thomas [1 ]
Mansur, Ayla [3 ]
Cotel, Marie-Caroline [2 ]
Wells, Lisa [4 ]
Creeney, Hannah [2 ]
Bonsall, David [4 ]
Rogdaki, Maria [1 ]
Shatalina, Ekaterina [1 ]
Marques, Tiago Reis [1 ]
Rabiner, Eugenii [4 ]
Gunn, Roger [3 ]
Natesan, Sridhar [2 ]
Vernon, Anthony [2 ]
Howes, Oliver D. [1 ]
机构
[1] Hammersmith Hosp, MRC London Inst Med Sci, London, England
[2] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England
[3] Imperial Coll London, London, England
[4] Invicro Imaging Serv, Boston, MA USA
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
O11.3
引用
收藏
页码:S28 / S28
页数:1
相关论文
共 50 条
  • [1] Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
    Ellis Chika Onwordi
    Els F. Halff
    Thomas Whitehurst
    Ayla Mansur
    Marie-Caroline Cotel
    Lisa Wells
    Hannah Creeney
    David Bonsall
    Maria Rogdaki
    Ekaterina Shatalina
    Tiago Reis Marques
    Eugenii A. Rabiner
    Roger N. Gunn
    Sridhar Natesan
    Anthony C. Vernon
    Oliver D. Howes
    Nature Communications, 11
  • [2] Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
    Onwordi, Ellis Chika
    Halff, Els F.
    Whitehurst, Thomas
    Mansur, Ayla
    Cotel, Marie-Caroline
    Wells, Lisa
    Creeney, Hannah
    Bonsall, David
    Rogdaki, Maria
    Shatalina, Ekaterina
    Marques, Tiago Reis
    Rabiner, Eugenii A.
    Gunn, Roger N.
    Natesan, Sridhar
    Vernon, Anthony C.
    Howes, Oliver D.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [3] Reductions in synaptic marker SV2A in early-course Schizophrenia
    Yoon, Jong H.
    Zhang, Zhener
    Mormino, Elizabeth
    Davidzon, Guido
    Minzenberg, Michael J.
    Ballon, Jacob
    Kalinowski, Agnieszka
    Hardy, Kate
    Naganawa, Mika
    Carson, Richard E.
    Khalighi, Mehdi
    Park, Jun Hyung
    Levinson, Douglas F.
    Chin, Frederick T.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2023, 161 : 213 - 217
  • [4] Increased seizure susceptibility in the synaptic vesicle protein SV2A mutant rats
    Okumura, Takahiro
    Ishihara, Shizuka
    Terada, Ryo
    Shimizu, Saki
    Tokudome, Kentaro
    Tomita, Chisato
    Kitaya, Ryousuke
    Tanaka, Tomoya
    Kunisawa, Naofumi
    Mashimo, Tomoji
    Serikawa, Tadao
    Sasa, Masashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 155P - 155P
  • [5] Hyperexcitability of the hippocampal neurons in the synaptic vesicle protein SV2A mutant rats
    Tokudome, Kentaro
    Okumura, Takahiro
    Shimizu, Saki
    Kunisawa, Naofumi
    Tomita, Chisato
    Kitaya, Ryosuke
    Mashimo, Tomoji
    Serikawa, Tadao
    Sasa, Masashi
    Ohno, Yukihiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 155P - 155P
  • [6] Developmental Expression of Synaptic Vesicle Protein SV2A
    Vendrame, Martina
    Talos, Delia
    Chang, Meayoung
    Jensen, Frances
    NEUROLOGY, 2009, 72 (11) : A347 - A347
  • [7] Increased sensitivity to methamphetamine in synaptic vesicle protein 2A (SV2A)-mutant rats
    Tokudome, Kentaro
    Shimizu, Saki
    Okumura, Takahiro
    Kunisawa, Naofumi
    Kihara, Sana
    Nakashima, Sanae
    Hashimoto, Aduki
    Hiraoka, Yuki
    Fukuda, Kazuki
    Mashimo, Tomoji
    Serikawa, Tadao
    Ohno, Yukihiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 123P - 123P
  • [8] Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia
    Mattheisen, Manuel
    Muehleisen, Thomas W.
    Strohmaier, Jana
    Treutlein, Jens
    Nenadic, Igor
    Alblas, Margrieta
    Meier, Sandra
    Degenhardt, Franziska
    Herms, Stefan
    Hoffmann, Per
    Witt, Stephanie H.
    Giegling, Ina
    Sauer, Heinrich
    Schulze, Thomas G.
    Rujescu, Dan
    Noethen, Markus M.
    Rietschel, Marcella
    Cichon, Sven
    SCHIZOPHRENIA RESEARCH, 2012, 141 (2-3) : 262 - 265
  • [9] NEGATIVE MODULATION OF THE SYNAPTIC VESICLE PROTEIN (SV2A): A NEW PHARMACOLOGICAL TARGET FOR COGNITIVE DEFICIT ASSOCIATED WITH SCHIZOPHRENIA
    Laruelle, Marc
    Detrait, Eric
    Lamberty, Yves
    Leclercq, Karine
    Jnoff, Eric
    Wood, Martin
    Gillard, Michel
    Jigorel, Emilie
    Klitgaard, Henrik
    Provins, Laurent
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S66 - S66
  • [10] Negative Modulation of the Synaptic Vesicle Protein (SV2A): A New Pharmacological Target for Cognitive Deficit Associated with Schizophrenia
    Detrait, Eric R.
    Laruelle, Marc
    Lamberty, Yves
    Leclercq, Karine
    Jnoff, Eric
    Wood, Martyn
    Gillard, Michel
    Jigorel, Emilie
    Klitgaard, Henrik
    Provins, Laurent
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 133S - 133S